Intrathoracic impedance monitoring to detect chronic heart failure deterioration:: Relationship to changes in NT proBNP

被引:40
作者
Luethje, Lars
Vollmann, Dirk
Drescher, Till
Schott, Peter
Zenker, Dieter
Hasenfuss, Gerd
Unterberg, Christina
机构
[1] Univ Gottingen, Herzzentrum Gottingen, Abt Kardiol & Pneumol, D-37075 Gottingen, Germany
[2] Univ Gottingen, Abt Thorax Herz Gefasschirurg, D-3400 Gottingen, Germany
关键词
cardiac resynchronisation therapy; intrathoracic impedance monitoring; chronic heart failure; NT-proBNP;
D O I
10.1016/j.ejheart.2007.03.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: An alert algorithm, based on intrathoracic impedance monitoring, has been incorporated into a cardiac resynchronisation device (CRT) to detect pulmonary fluid accumulation, and to audibly alert patients to decompensating chronic heart failure (CHF). Aims: To evaluate this algorithm, alert events were correlated with changes in NT-proBNP concentration and CHF status. Methods and results: In a prospective observational study of 62 patients (89% male, aged 67 +/- 1 year), NT proBNP plasma concentrations, clinical CHF status, and device data were collected at enrolment, during regular follow-up and at device alerts. Over a mean follow-up of 27 +/- 2 weeks, pooled data indicated a weak, but significant inverse relationship between relative changes in intrathoracic impedance and NT proBNP (r=-0.3; p < 0.001). In 52 device alerts from 35 patients, NT proBNP increased by 66 +/- 19% from 2039 +/- 1331 pg/ml (p < 0.001). The increase in NT proBNP was higher in alerts with clinical signs of CHF deterioration (n = 30, 89 +/- 25%;p < 0.001) than in alert events without clinical signs (n = 22, 25 +/- 15%; p = n.s.). Conclusion: Intrathoracic impedance based alert events are associated with a significant increase in NT-proBNP concentration. These data indicate that intrathoracic impedance monitoring might facilitate the outpatient management of CHF patients with implanted CRT devices. 2007 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:716 / 722
页数:7
相关论文
共 25 条
[1]   Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [J].
Adams, KF ;
Fonarow, GC ;
Emerman, CL ;
LeJemtel, TH ;
Costanzo, MR ;
Abraham, WT ;
Berkowitz, RL ;
Galvao, M ;
Horton, DP .
AMERICAN HEART JOURNAL, 2005, 149 (02) :209-216
[2]   Development of implantable devices for continuous ambulatory monitoring of central hemodynamic values in heart failure patients [J].
Bennett, T ;
Kjellstrom, B ;
Taepke, R ;
Ryden, L .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (06) :573-584
[3]   N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients [J].
Bettencourt, P ;
Azevedo, A ;
Pimenta, J ;
Frioes, F ;
Ferreira, S ;
Ferreira, A .
CIRCULATION, 2004, 110 (15) :2168-2174
[4]   Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure [J].
Braunschweig, Frieder ;
Fahrleitner-Pammer, Astrid ;
Mangiavacchi, Maurizio ;
Ghio, Stefano ;
Fotuhi, Parwis ;
Hoppe, Uta C. ;
Linde, Cecilia .
EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (08) :797-803
[5]   The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis [J].
Cleland, JGF ;
Swedberg, K ;
Follath, F ;
Komajda, M ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Gavazzi, A ;
Hobbs, R ;
Korewicki, J ;
Madeira, HC ;
Moiseyev, VS ;
Preda, I ;
van Gilst, WH ;
Widimsky, J ;
Freemantle, N ;
Eastaugh, J ;
Mason, J .
EUROPEAN HEART JOURNAL, 2003, 24 (05) :442-463
[6]   B-type natriuretic peptide in cardiovascular disease [J].
de Lemos, JA ;
McGuire, DK ;
Drazner, MH .
LANCET, 2003, 362 (9380) :316-322
[7]   Cardiac resynchronization induces favorable neurohumoral changes [J].
Erol-Yilmaz, A ;
Verberne, HJ ;
Schrama, TA ;
Hrudova, J ;
De Winter, RJ ;
Van Eck-Smit, BLF ;
De Bruin, R ;
Bax, JJ ;
Schalij, MJ ;
Wilde, AA ;
Tukkie, R .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (04) :304-310
[8]   Overview of acutely decompensated congestive heart failure (ADHF): A report from the ADHERE Registry [J].
Fonarow, GC .
HEART FAILURE REVIEWS, 2004, 9 (03) :179-185
[9]   N-terminal pro-brain natriuretic peptide -: A new gold standard in predicting mortality in patients with advanced heart failure [J].
Gardner, RS ;
Özalp, F ;
Murday, AJ ;
Robb, SD ;
McDonagh, TA .
EUROPEAN HEART JOURNAL, 2003, 24 (19) :1735-1743
[10]   Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure - A substudy of the carvedilol prospective randomized cumulative survival (COPERNICUS) trial [J].
Hartmann, F ;
Packer, M ;
Coats, AJS ;
Fowler, MB ;
Krum, H ;
Mohacsi, P ;
Rouleau, JL ;
Tendera, M ;
Castaigne, A ;
Anker, SD ;
Amann-Zalan, I ;
Hoersch, S ;
Katus, HA .
CIRCULATION, 2004, 110 (13) :1780-1786